[PDF] Top 20 Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
Has 10000 "Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation" found on our website. Below are the top 20 most common "Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation".
Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
... on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation ... Voir le document complet
4
Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
... (FB) and fludarabine plus melphalan (FM) are 2 widely used reduced-intensity conditioning (RIC) regimens for allogeneic hematopoietic stem cell ... Voir le document complet
8
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
... hematopoietic stem cell transplantation (allo-SCT) is the most effective post-remission treatment for adults with high-risk acute lymphoblastic ... Voir le document complet
12
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies
... nature of this study, it cannot be concluded that more intensive conditioning leads to lower non-relapse mortality ...rates. The choice of the busulfan dose was, in fact, based ... Voir le document complet
8
Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning
... ciated with better survival than truly nonmyeloablative conditioning because of a possibly lower incidence of re- lapse and similar non-relapse ...be the case. Blaise et ... Voir le document complet
7
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
... model for overall mortality (OM) at day 100. The ADT consists of alternating levels of prediction (ellipses) and decision nodes ...associated with a weight, representing ... Voir le document complet
10
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
... demographics A total of 1,013 AML patients who underwent HLA mismatched allo- geneic stem cell transplantation between 2005 and 2014 was identi- fied and ...most ... Voir le document complet
8
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT
... design and data collection This was a retrospective multicenter ...provided and approved for this study by the acute leukemia working party (ALWP) of ... Voir le document complet
13
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT
... - patients in terms of both leukemia control and transplant associated ...outcome of adult patients as a whole has decidedly improved over the past decade [14], ... Voir le document complet
8
Prediction of Hematopoietic Stem Cell Transplantation Related Mortality-Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study
... encountered. A new score, based on integrated feature of the comorbidity index and EBMT score, was constructed achieving an AUC of ...AUC of 0.65 using only 3–5 variables. Adding ... Voir le document complet
15
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chronic malignancies working party
... (IgG) in 48% of patients, light chain in 26% and immunoglobulin A (IgA) in ...were in stage III according to the International Staging System (ISS) ...absent ... Voir le document complet
4
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
... leukemia In ALL, one major question is the use of glucocorticoids, as they remain essential components of ALL ...effective in reducing immunopathological damage [ 16 ], but there are ... Voir le document complet
5
Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey
... 20,28,29,34 The longer med- ian OS in the AZA-001 trial probably resulted from the more stringent eligibility criteria of clinical trials compared with real-life ...studies. ... Voir le document complet
10
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT.
... Results Patients and donors Data from 2963 patients with primary or secondary AML were included in this study (Table 1 ...five patients underwent a single (n = 175) ... Voir le document complet
7
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT
... type and transplantation outcomes were evaluated in multivariable analyses, using Cox proportional ...control for pre-treatment imbalances on observed variables. The following factors ... Voir le document complet
8
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
... design and data collection This was a retrospective multicenter analysis using the dataset of the Acute Leukemia Working Party (ALWP) of the ... Voir le document complet
12
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC
... one of the main causes of morbidity and mortality after allo-SCT, strategies to improve outcomes of patients were developed thereafter, including modification of ... Voir le document complet
11
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.
... Sloand and coworkers described results in 12 patients (median age 43 years) given G-PBMC from HLA-iden- tical siblings after conditioning with cyclophosphamide (120 mg/kg) and fl ... Voir le document complet
15
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)
... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...Kinetics of engraftment in patients with hematologic malignancies given ... Voir le document complet
7
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial
... known risk factors for treatment outcome, such as tumor mass (WBC more than 30 × 10 9 /L) and the patient’s age (> 35 years of age), had no impact on the difference in ... Voir le document complet
9
Sujets connexes